198 related articles for article (PubMed ID: 5125072)
1. [Amantadine hydrochloride in patients with parkinsonism in a Geriatric Rehabilitation Center].
Antonini FM; Baroni A
Minerva Med; 1971 Oct; 62(82):4027-30. PubMed ID: 5125072
[No Abstract] [Full Text] [Related]
2. Amantadine hydrochloride in treatment of Parkinsonism.
Nagaswami S; Nagaswami R
Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
[No Abstract] [Full Text] [Related]
3. [Long-term effects of amantadine in striatal syndromes].
Rovetta P
Minerva Med; 1971 Oct; 62(82):3965-7. PubMed ID: 5125054
[No Abstract] [Full Text] [Related]
4. [Experience in the prolonged use of midantan (amantadine hydrochloride) in parkinsonism].
Man'kovskii NB; Vainshtok AB; Oleinik LI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):524-30. PubMed ID: 4705407
[No Abstract] [Full Text] [Related]
5. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation].
Antonini F; Baroni A; Roveyaz L
Sist Nerv; 1970; 22(2):74-81. PubMed ID: 5504560
[No Abstract] [Full Text] [Related]
6. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes].
Kiseleva AM; Zlydnikov DM; Mazhinskaia VP; Lebedeva VK; Zakharova NG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):530-4. PubMed ID: 4705408
[No Abstract] [Full Text] [Related]
7. [Combined treatment of Parkinsonism with levopa, midantan and anticholinergic drugs].
Evtushenko SK
Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Dec; 76(12):1797-1802. PubMed ID: 1015115
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of the Parkinson syndrome with amantadine].
Hartmann-von Monakow K
Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093
[No Abstract] [Full Text] [Related]
9. [Catecholamine excretion and treatment of parkinsonism with midantan].
Kandel' EI; Iadgarov IS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Sep; 76(9):1323-6. PubMed ID: 1015136
[No Abstract] [Full Text] [Related]
10. [On the action of amantadine in postencephalitic parkinsonism].
Pennacchietti M; Aletto PM
Minerva Med; 1971 Oct; 62(82):3960-2. PubMed ID: 5125052
[No Abstract] [Full Text] [Related]
11. [The effectiveness of amantadine (midantan) in the treatment of the parkinsonian syndrome].
Kadykov AS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(2):174-8. PubMed ID: 944514
[TBL] [Abstract][Full Text] [Related]
12. [Results of treatment of Parkinsonism with L-dopa].
De Divitiis E; D'Andrea F; Signorelli CD
Sist Nerv; 1970; 22(2):99-108. PubMed ID: 5504563
[No Abstract] [Full Text] [Related]
13. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
Sigwald J; Raymondeaud C; Piot C
Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
[No Abstract] [Full Text] [Related]
14. [Quantitative testing methods for objectification of the effect of prolonged L-dopa therapy in parkinsonism].
Gerstenbrand F; Grünberger J; Schubert H
Nervenarzt; 1973 Aug; 44(8):428-33. PubMed ID: 4733895
[No Abstract] [Full Text] [Related]
15. [Our experience in the treatment of the parkinsonian syndrome with L-dopa. I. Evaluation of the clinical results].
Bergamini L; Bonzanino O; Brignolio F; Fabiani A; Fariello R; Mombelli AM; Mutani R; Pisani W; Postir A; Riccio A; Sabbatini F; Sandigliano G; Schiffer D
Riv Patol Nerv Ment; 1969 Oct; 90(5):329-49. PubMed ID: 5406104
[No Abstract] [Full Text] [Related]
16. [Trans-cerebral electrophoresis of L-DOPA in the complex treatment of parkinsonism].
Neĭmark EZ; Evtushenko SK; Dukhovnaia MA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1334-8. PubMed ID: 6506979
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of Parkinsonian syndrome using amantadine hydrochloride].
Schubert U; Fischer GJ; Glass J
Z Arztl Fortbild (Jena); 1975 May; 69(9):469-76. PubMed ID: 1106004
[No Abstract] [Full Text] [Related]
18. [Nil nocere. Adverse effects of amantadine therapy of parkinsonism. Summary to E.W. Fünfgeld: "Long-time therapy of parkinsonism with amantadine sulfate" and to G. Völler: "Amantadine therapy of parkinsonism"].
Diehl LW
Munch Med Wochenschr; 1972 Jun; 114(22):1068. PubMed ID: 5068023
[No Abstract] [Full Text] [Related]
19. Combined treatment of parkinsonism with L-dopa and amantadine.
Godwin-Austen RB; Frears CC; Bergmann S; Parkes JD; Knill-Jones RP
Lancet; 1970 Aug; 2(7669):383-5. PubMed ID: 4194690
[No Abstract] [Full Text] [Related]
20. Treatment failures with L-dopa in Parkinsonism.
Julsrud OJ
Acta Neurol Scand Suppl; 1972; 51():123-4. PubMed ID: 4514337
[No Abstract] [Full Text] [Related]
[Next] [New Search]
